Drug Patents owned by Sun Pharm Industries

1. List of Ultravate drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8962028 SUN PHARM INDUSTRIES Topical steroid composition and method
Jun, 2033

(10 years from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) Aug 31, 2023

Drugs and Companies using HALOBETASOL PROPIONATE ingredient

Market Authorisation Date: 06 November, 2015

Treatment: Use of a lotion containing halobetasol propionate for the treatment of corticosteroid-responsive dermatoses including psoriasis


How can I launch a generic of ULTRAVATE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in